Clinical Trial Update: Efficacy and Safety of Ypeginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of Ypeginterferon Alfa-2b in HBeAg-positive chronic hepatitis B has completed. This update summarizes the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Ypeginterferon Alfa-2b (pegylated interferon alfa-2b)

Snippet

Sponsor: Xiamen Amoytop Biotech Co., Ltd. | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED